| Dr Heath Gilman Foster, DC | |
|
366 River St, Springfield, VT 05156-2242 | |
| (802) 886-2555 | |
| Not Available |
| Full Name | Dr Heath Gilman Foster |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 12 Years |
| Location | 366 River St, Springfield, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104161744 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 006.0125754 (Vermont) | Primary |
| Provider Name | Charles L Foster Dc Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1730416041 PECOS PAC ID: 4183754237 Enrollment ID: O20100616000243 |
News Archive
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Today keynote speaker Congresswoman Nita Lowey (NY-18) joined with experts from New York Presbyterian Hospital; the Skin Cancer Foundation; 2006 Miss Maryland, a skin cancer survivor; Fallene LTD, and Ciba Corporation to call on the Food and Drug Administration (FDA) to address the dramatic rise in skin cancer rates in the United States.
Artegraft, Inc. announces that a three-year prospective, randomized clinical study published in the June 2011 issue of the Journal of Vascular Surgery confirms the superiority of Artegraft Bovine Carotid Artery vascular grafts (BCA) to cuffed ePTFE grafts.
Once a hospital reaches a certain occupancy level, the quality of care it provides deteriorates, increasing the risk of mortality of critically ill patients. What is worrying is that this safety 'tipping point' is reached at occupancy levels that are below 100%.
› Verified 1 days ago
| Provider Name | Fostering Wellness Springfield Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568992824 PECOS PAC ID: 2365713385 Enrollment ID: O20170809000629 |
News Archive
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Today keynote speaker Congresswoman Nita Lowey (NY-18) joined with experts from New York Presbyterian Hospital; the Skin Cancer Foundation; 2006 Miss Maryland, a skin cancer survivor; Fallene LTD, and Ciba Corporation to call on the Food and Drug Administration (FDA) to address the dramatic rise in skin cancer rates in the United States.
Artegraft, Inc. announces that a three-year prospective, randomized clinical study published in the June 2011 issue of the Journal of Vascular Surgery confirms the superiority of Artegraft Bovine Carotid Artery vascular grafts (BCA) to cuffed ePTFE grafts.
Once a hospital reaches a certain occupancy level, the quality of care it provides deteriorates, increasing the risk of mortality of critically ill patients. What is worrying is that this safety 'tipping point' is reached at occupancy levels that are below 100%.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heath Gilman Foster, DC 1880 Charles Hennessee Rd, Sparta, TN 38583-2768 Ph: (309) 318-9126 | Dr Heath Gilman Foster, DC 366 River St, Springfield, VT 05156-2242 Ph: (802) 886-2555 |
News Archive
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.
Today keynote speaker Congresswoman Nita Lowey (NY-18) joined with experts from New York Presbyterian Hospital; the Skin Cancer Foundation; 2006 Miss Maryland, a skin cancer survivor; Fallene LTD, and Ciba Corporation to call on the Food and Drug Administration (FDA) to address the dramatic rise in skin cancer rates in the United States.
Artegraft, Inc. announces that a three-year prospective, randomized clinical study published in the June 2011 issue of the Journal of Vascular Surgery confirms the superiority of Artegraft Bovine Carotid Artery vascular grafts (BCA) to cuffed ePTFE grafts.
Once a hospital reaches a certain occupancy level, the quality of care it provides deteriorates, increasing the risk of mortality of critically ill patients. What is worrying is that this safety 'tipping point' is reached at occupancy levels that are below 100%.
› Verified 1 days ago
Terrance Ryan, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 366 River St, Suite 2, Springfield, VT 05156 Phone: 802-886-2555 Fax: 802-886-2002 | |
Fostering Wellness Springfield Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 366 River St, Springfield, VT 05156 Phone: 802-886-2555 Fax: 802-886-2002 | |
Dr. James Rizzo, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 160 Wall Street, Springfield, VT 05156 Phone: 802-885-1600 Fax: 802-885-1600 |